Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

RFK Jr. Walks Back Wearables Message Amid Data Concerns No Photo Available

Yeji Jesse Lee

Amid pushback about mass data collection and privacy risks, U.S. Department of Health and Human Services Secretary Robert Kennedy Jr. ... (more story)

High Court Ruling Puts Limits On Medicaid Enforcement No Photo Available

Dan McKay

The U.S. Supreme Court ruling that bars a Medicaid beneficiary from suing over her right to choose a medical provider could make more ... (more story)

Justices Face Busy Summer After Nixing Universal Injunctions No Photo Available

Katie Buehler

The U.S. Supreme Court's decision to limit nationwide injunctions was one of its biggest rulings of the term — a finding the court is ... (more story)